
<rss version="2.0">
  <channel>
    <title>Y! Health Lymphoma News</title>
    <link>http://us.rd.yahoo.com/health/news/rss/search/*http://health.yahoo.com/news/</link>
    <description>Y! Health Lymphoma News, updated continuously.</description>
    <language>en-us</language>
    <lastBuildDate>Thu, 26 Nov 2009 04:16:20 PST</lastBuildDate>
    <copyright>Copyright (c) 2009 Yahoo! Inc. All rights reserved.</copyright>
    <ttl>5</ttl>
    <image>
      <title>Yahoo! Health</title>
      <width>142</width>
      <height>18</height>
      <link>http://health.yahoo.com/</link>
      <url>http://us.i1.yimg.com/us.yimg.com/i/us/he/b/he_144.gif</url>
    </image><item><title>Istodax Approved for Cutaneous T-Cell Lymphoma (HealthDay)</title><link>http://us.rd.yahoo.com/health/news/rss/search/*http://health.yahoo.com/news/healthday/istodaxapprovedforcutaneoustcelllymphoma.html</link><guid isPermaLink="false">yahoo/health/news/healthday/istodaxapprovedforcutaneoustcelllymphoma</guid><pubDate>Fri, 06 Nov 2009 20:48:31 PST</pubDate><description>HealthDay - FRIDAY, Nov. 6 (HealthDay News) -- The Gloucester Pharmaceuticals 
drug Istodax (romidepsin) has been approved by the U.S. Food and Drug 
Administration to treat cutaneous T-cell lymphoma (CTCL) in people who 
have tried at least one prior systemic therapy, the drug's manufacturer 
said in a news release.</description></item>  </channel>
</rss>
<!-- health:health-us:0:Success -->
<!-- fe3.health.re1.yahoo.com uncompressed/chunked Thu Nov 26 06:51:52 PST 2009 -->
